Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://xitter.cf/t.co/CBx3GZBv31
Joined July 2015
- Tweets89.5K
- Following4.7K
- Followers165K
- Likes45K
Pinned Tweet
This year, as in past years, we’ve found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the biggest questions in science and medicine.
Meet the 2026 #STATWunderkinds!
statnews.com/wunderkinds/
After years of steep increases, especially amid the pandemic, U.S. overdose deaths decreased 27% in 2024, and preliminary data from 2025 show another meaningful drop. trib.al/BQmZ4Rr
Data add to expectations that the drug will be one of Lilly’s greatest growth drivers. trib.al/QJex0Nc
STAT is looking to learn, from people with direct knowledge, how Epic's actions impact hospitals' technology choices. Share your story with us. trib.al/IITJvID
“A few years ago, I froze my eggs — and the experience was anything but empowering,” writes physician Pooja Yerramilli. trib.al/2iDL18q
A STAT investigation found that Epic selectively withholds access to patient data, disadvantaging rival software developers and stymying innovation. trib.al/0VIfaeG
“It is dizzying to have a family clamoring for the MMR vaccine in one room while the room next door adamantly opposes vaccination,” writes a pediatrician. trib.al/7Tw0qEE
Meet STAT Wunderkind — he's working on documenting LGBTQ+ disparities, then dissolving them.
Read more about his work: statnews.com/wunderkinds/aus…
#STATWunderkinds
ALT This image is a promotional graphic titled "STAT Wunderkinds '26". It features a person smiling, with short hair and a beard, wearing glasses and a white shirt. The text identifies the person as Austin Waters, associated with Dana-Farber Cancer Institute/Harvard LGBTQ Health Center of Excellence.
Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own trib.al/QHrR4xm
Meet STAT Wunderkind Baldeep Dhaliwal — she's working to keep community health workers safe during disease outbreaks. Read more about her work: statnews.com/wunderkinds/bal…
#STATWunderkinds
ALT "Image of a smiling individual with long hair, dressed in a patterned top, against a background of various faded faces. Text: 'STAT Wunderkinds '26'. Name: Baldeep K. Dhaliwal, with pronouns she/her, associated with Johns Hopkins Berman Institute of Bioethics."
Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign more states are pushing back against drugmakers. trib.al/ozKm4JV
A cow got gene therapy. Patients are still waiting. statnews.com/2026/10/27/gene…
Artiva Biotherapeutics said that it’s winding down after two patients died in a trial testing its cell therapy for autoimmune diseases, the latest in a series of safety events that emerged in a promising research field. bit.ly/4ijeKIV
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases. trib.al/005zYiW
#Breaking: FDA offers new details on quicker approval pathway for personalized gene therapies statnews.com/2026/10/27/fda-…
Rare disease advocates applauded the FDA's move to speed access to treatments. trib.al/EzJF2jR
A gene therapy saved a calf with a rare genetic disease. Years later, Mennonite families work to develop the therapy on their own after biotech ignored it. statnews.com/2026/10/27/gene…
Kennedy on the campaign trail for MAHA, and new rules loom for U.S. investments in Chinese biotech. trib.al/hQn8X1Y
"The question is no longer whether personalized cancer vaccines can work. The question now becomes how to accelerate development and increase access for the patients who could benefit." statnews.com/2026/10/27/canc…
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program: trib.al/UmLHmsB
STAT retweeted
There is no better reporter anywhere covering rare diseases than STAT's @Jasonmmast. Today, another masterpiece:
Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own statnews.com/2026/10/27/gene…